Press Releases from Curetis AG (10 total)
Mayo Clinic’s Dr. Robin Patel Named Principal Investigator for Curetis’ Unyv …
− Curetis adds six new trial sites, significantly expanding U.S. clinical trial network for ongoing FDA study
Holzgerlingen, Germany, May 14, 2014 -- Curetis AG, a…
Curetis AG Initiates Clinical Trial in the U.S. Towards FDA Clearance
- Prospective Multi-Center Trial to Enroll Over 2,000 Clinical Samples -
Holzgerlingen, Germany, December 6, 2012 -- Curetis AG today announced the start of a clinical…
Curetis and Scholz Collaborate to Industrialize and Scale-Up Production of Unyve …
- German family firm ‘Scholz-HTIK – High Tech in Kunststoff’ has been selected by Curetis based on systematic benchmarking process -
Holzgerlingen (Germany), December 4, 2012…
Curetis Completes Enrollment for its EU Trial As Planned
- Prospective multi-center trial enrolls 800 patient samples in 7 months -
Holzgerlingen (Germany), October 9, 2012 -- Curetis AG today announced it has completed enrollment…
Curetis AG Signs Up BioLine LLC as Exclusive Distribution Partner for Russia
- Partners to start registration process and market launch in Russia -
Holzgerlingen, Germany, September 27, 2012 -- Curetis AG today announced that it has signed…
Curetis AG Chooses Mediphos as Exclusive Distribution Partner for the Netherland …
- Partners prepare market launch and clinical evaluation project -
Holzgerlingen, Germany, September 26, 2012 -- Curetis AG today announced that Curetis and Mediphos have closed…
Curetis and Heraeus Medical Collaborate on the Development of New Unyvero™ Dia …
- Joint development of cartridge for orthopaedics, wound and surgery infections -
Holzgerlingen and Wehrheim (Germany), September 20, 2012 -- Curetis AG and Heraeus Medical…
Curetis AG Signs Distribution Deal in Middle East with ATC
- Kuwait Ministry of Health clears Unyvero™ Solution for clinical evaluation -
Holzgerlingen, Germany, July 18, 2012 -- Curetis AG, an innovative molecular diagnostics company focusing…
Curetis AG Achieves CE-Marking for Unyvero™ Solution and Initiates Commerciali …
- Successful completion of performance evaluation study; CE Mark for Unyvero™ instrument system and pneumonia application -
Holzgerlingen, Germany, May 14, 2012 -- Curetis AG, an…
Curetis AG to Present Its Unyvero™ System for Pneumonia Diagnostics
- Demonstration supported by symposium on bacterial pneumonia and emerging antibiotic resistance at the 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) -
Holzgerlingen,…
Go To Page:
